Company / Capital Returned to Shareholders
UTAH MEDICAL PRODUCTS INC Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$4.3M
FY2025
5-year range
$4.3M / $11.5M
FY2021-FY2025
Trend
-24.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $3M in FY2019 to $11M in FY2023.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -3.9%.
Declined from $11M to $4M over the past 2 years.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -27.2%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.9%, indicating a declining trend.
- In FY2025, capital returned to shareholders decreased 24.3% year-over-year.
- Peak capital returned to shareholders was recorded in FY2023.
- Lowest capital returned to shareholders in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.3M | -24.3% |
| FY2024 | $5.7M | -50.6% |
| FY2023 | $11.5M | +3.4% |
| FY2022 | $11.1M | +145.9% |
| FY2021 | $4.5M | -13.8% |
| FY2020 | $5.2M | +77.0% |
| FY2019 | $3.0M | -24.5% |
| FY2018 | $3.9M | +1.8% |
| FY2017 | $3.8M | +2.2% |
| FY2016 | $3.8M | +2.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026